Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-03-12
1977-04-12
Drezin, Norman A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3112
Patent
active
040176398
ABSTRACT:
Substituted naphthoquinones of the formula (I) and pharmaceutically acceptable salts thereof wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 represent alkyl, aryl, alkoxy, hydroxy, hydrogen or halogen or any two of the groups R.sub.1, R.sub.2, R.sub.3 and R.sub.4 taken together complete a carbocyclic ring, have useful anti-allergy activity in mammals.
REFERENCES:
patent: 3833726 (1974-09-01), Schwender et al.
patent: 3920845 (1975-11-01), Smith et al.
Vladimirtsev et al., Chemical Abstracts 73:1190f, (1970).
Ikeda et al., Chemical Abstracts 50:3358d, (1956).
Buckle Derek Richard
Cantello Barry Christian Charles
Smith Harry
Beecham Group Limited
Drezin Norman A.
LandOfFree
2-Hydroxy-3-nitro-1,4-naphthoquinones for the prophylaxis of cer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-Hydroxy-3-nitro-1,4-naphthoquinones for the prophylaxis of cer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-Hydroxy-3-nitro-1,4-naphthoquinones for the prophylaxis of cer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1281954